Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Legal & General Group Plc
Legal & General Group Plc decreased its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 5.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,064 shares of the biopharmaceutical company’s stock after selling 15,329 shares during the quarter. […]
Legal & General Group Plc decreased its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 5.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,064 shares of the biopharmaceutical company’s stock after selling 15,329 shares during the quarter. […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}
